AGEN vs ELV · P/E 1.6, rev $68.3M vs P/E 18, rev $199.13B
Agenus Inc (AGEN) versus Elevance Health Inc (ELV) — a side-by-side from cached financials, not a winner call.
Agenus Inc (AGEN) is a biotechnology company listed on US.
Elevance Health Inc (ELV) is a healthcare plans company listed on US.
Latest reported AGEN revenue for 2026-06-30 was $68.3M. Net income was $38.6M. AGEN currently screens at market cap $134.5M and trailing P/E 1.6.
Latest reported ELV revenue for 2025-12-31 was $199.13B. Net income was $5.66B. Revenue was up 12.5% from 2024-12-31 to 2025-12-31. ELV currently screens at market cap $90.24B and trailing P/E 17.6.
AGEN currently screens at market cap $134.5M and trailing P/E 1.6. ELV currently screens at market cap $90.24B and trailing P/E 17.6.
Not investment advice. Open the AGEN and ELV stock pages for the full models.
Not investment advice.